Cashu | News | JNJ

HomeWatchlistNewsSignalsPicks

DJI

-0.10%

SPX

-0.03%

IXIC

+0.13%

FTSE

+0.11%

N225

-0.74%

AXJO

-0.02%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Privacy Policy
Terms of Use

Instagram YouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Stocks

Health Care

jnj

Johnson & Johnson

JNJ

-1.61 (-1.06%)

150.77

USD

At close at Jun 18, 20:34 UTC

Latest Johnson & Johnson News

Peering Into Johnson & Johnson's Recent Short Interest

Democrats press Pfizer, J&J and others over low tax bills and lobbying as Senate debates Trump's plan

Feature Image for interests on Biotech And Pharmaceuticals, Biotechnology, Breaking News: Business, Breaking News: Politics from cnbc.com

Investigational combination of first-in-class bispecifics TALVEY and TECVAYLI shows deep and durable responses in heavily pretreated multiple myeloma patients with extramedullary disease

Feature Image for interests on Health Care & Hospitals, Healthcare, Medical Pharmaceuticals, Pharmaceuticals from prnewswire.com

Johnson & Johnson's dual-targeting CAR T-cell therapy shows encouraging first results in large B-cell lymphoma

Feature Image for interests on Clinical Trials & Medical Discoveries, Health Care & Hospitals, Healthcare, Industrials from prnewswire.com

New results for Johnson & Johnson's bleximenib demonstrate promising antileukemic activity in combination with venetoclax and azacitidine for acute myeloid leukemia

Feature Image for interests on Healthcare, Johnson & Johnson, Stock from prnewswire.com

New data show TREMFYA (guselkumab) is the only IL-23 inhibitor proven to significantly inhibit progression of joint structural damage in active psoriatic arthritis

Feature Image for interests on Clinical Trials & Medical Discoveries, Health Care & Hospitals, Healthcare, Medical Pharmaceuticals from prnewswire.com

Johnson & Johnson denies engaging in illegal DEI practices after group makes civil rights complaint

12 Analysts Have This To Say About Johnson & Johnson

Dr Reddy's And Alvotech Join Hands To Develop Biosimilar For Merck's Blockbuster Cancer Drug

Feature Image for interests on Briefs, Health Care, Healthcare, News from benzinga.com

Health care stocks are due for a turnaround after a historically bad month, according to the charts

Feature Image for interests on Breaking News: Markets, ETF, Healthcare, Markets from cnbc.com

Latest Cashu News

Johnson & Johnson Faces Intense Scrutiny Over Tax Practices Amid Pharmaceutical Industry Controversy

about 4 hours ago

Johnson & Johnson's TALVEY and TECVAYLI Show Promise in Treating Multiple Myeloma

Johnson & Johnson's JNJ-4496 Shows Promise in Treating Aggressive Lymphoma